Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
This study will compare the pharmacokinetics of a single dose of peginterferon alfa-2b
(Sylatron®) in healthy participants to that in participants with moderate to severe
impairment of kidney function.